Presentation and Q&A session scheduled for
post-market on Monday, August 15,
2022
BOSTON, Aug. 8, 2022
/PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal
platform for cell programming, announced today that it plans to
host a presentation and Q&A session reviewing business
performance for the second quarter ended June 30, 2022, on Monday,
August 15, 2022, beginning at 4:30
p.m. ET.
The presentation details and webcast link will be available on
Ginkgo's investor relations website at
https://investors.ginkgobioworks.com, and a replay will be made
available.
To ask a question ahead of the presentation, please submit them
to @Ginkgo on Twitter (hashtag #GinkgoResults) or by sending an
e-mail to investors@ginkgobioworks.com.
About Ginkgo Bioworks
Ginkgo is building a platform to enable customers to program
cells as easily as we can program computers. The company's platform
is enabling biotechnology applications across diverse markets, from
food and agriculture to industrial chemicals to pharmaceuticals.
Ginkgo has also actively supported a number of COVID-19 response
efforts, including K-12 pooled testing, vaccine manufacturing
optimization and therapeutics discovery. For more information,
visit https://www.ginkgobioworks.com/.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
investors@ginkgobioworks.com
MEDIA CONTACT:
press@ginkgobioworks.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-second-quarter-2022-results-presentation-301601471.html
SOURCE Ginkgo Bioworks